Marshall Wace’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $58M | Buy |
807,534
+792,090
| +5,129% | +$61M | 0.06% | 314 |
|
|
2025
Q4 | $1.23M | Sell |
15,444
-3,649,256
| -100% | -$288M | ﹤0.01% | 1829 |
|
|
2025
Q3 | $276M | Buy |
3,664,700
+1,930,505
| +111% | +$132M | 0.28% | 51 |
|
|
2025
Q2 | $120M | Sell |
1,734,195
-1,992,101
| -53% | -$131M | 0.13% | 133 |
|
|
2025
Q1 | $252M | Buy |
3,726,296
+3,041,644
| +444% | +$182M | 0.32% | 46 |
|
|
2024
Q4 | $30.7M | Sell |
684,652
-771,264
| -53% | -$43.3M | 0.04% | 417 |
|
|
2024
Q3 | $91.5M | Buy |
1,455,916
+1,365,188
| +1,505% | +$79.6M | 0.11% | 157 |
|
|
2024
Q2 | $5.36M | Sell |
90,728
-1,587,180
| -95% | -$99.3M | 0.01% | 970 |
|
|
2024
Q1 | $134M | Sell |
1,677,908
-3,168,513
| -65% | -$242M | 0.2% | 93 |
|
|
2023
Q4 | $383M | Buy |
4,846,421
+2,206,666
| +84% | +$157M | 0.65% | 22 |
|
|
2023
Q3 | $184M | Sell |
2,639,755
-1,525,039
| -37% | -$108M | 0.37% | 47 |
|
|
2023
Q2 | $288M | Buy |
4,164,794
+1,526,001
| +58% | +$109M | 0.56% | 19 |
|
|
2023
Q1 | $196M | Buy |
2,638,793
+2,485,840
| +1,625% | +$208M | 0.42% | 39 |
|
|
2022
Q4 | $14.3M | Buy |
152,953
+91,905
| +151% | +$8.87M | 0.03% | 616 |
|
|
2022
Q3 | $5.82M | Sell |
61,048
-123,212
| -67% | -$12.2M | 0.01% | 1262 |
|
|
2022
Q2 | $17.1M | Sell |
184,260
-471,852
| -72% | -$46.1M | 0.04% | 542 |
|
|
2022
Q1 | $66.4M | Buy |
656,112
+235,259
| +56% | +$24.7M | 0.13% | 168 |
|
|
2021
Q4 | $43.4M | Buy |
420,853
+376,824
| +856% | +$34.8M | 0.08% | 249 |
|
|
2021
Q3 | $3.74M | Sell |
44,029
-98,570
| -69% | -$8.26M | 0.02% | 1131 |
|
|
2021
Q2 | $11.9M | Sell |
142,599
-267,887
| -65% | -$21.9M | 0.05% | 404 |
|
|
2021
Q1 | $30.9M | Buy |
410,486
+399,334
| +3,581% | +$29.1M | 0.14% | 145 |
|
|
2020
Q4 | $762K | Sell |
11,152
-426,016
| -97% | -$27.7M | ﹤0.01% | 1318 |
|
|
2020
Q3 | $25.5M | Buy |
437,168
+193,894
| +80% | +$12.1M | 0.16% | 132 |
|
|
2020
Q2 | $15.8M | Sell |
243,274
-651,918
| -73% | -$41.1M | 0.11% | 196 |
|
|
2020
Q1 | $53.1M | Buy |
895,192
+372,951
| +71% | +$24.9M | 0.53% | 36 |
|
|
2019
Q4 | $38.8M | Buy |
522,241
+146,124
| +39% | +$10.3M | 0.27% | 88 |
|
|
2019
Q3 | $23.7M | Buy |
376,117
+210,424
| +127% | +$12.5M | 0.19% | 124 |
|
|
2019
Q2 | $9.03M | Buy |
+165,693
| New | +$8.92M | 0.07% | 309 |
|
|
2019
Q1 | – | Sell |
-17,817
| Closed | -$1.17M | – | 1776 |
|
|
2018
Q4 | $1.17M | Sell |
17,817
-79,992
| -82% | -$5.97M | 0.01% | 871 |
|
|
2018
Q3 | $7.7M | Sell |
97,809
-45,097
| -32% | -$3.22M | 0.07% | 361 |
|
|
2018
Q2 | $9.2M | Buy |
+142,906
| New | +$9.42M | 0.14% | 189 |
|
|
2018
Q1 | – | Sell |
-3,488
| Closed | -$253K | – | 572 |
|
|
2017
Q4 | $253K | Sell |
3,488
-86,663
| -96% | -$6.3M | 0.01% | 364 |
|
|
2017
Q3 | $7.3M | Buy |
+90,151
| New | +$7.13M | 0.34% | 68 |
|
|
2017
Q1 | – | Sell |
-504,781
| Closed | -$39.8M | – | 401 |
|
|
2016
Q4 | $39.8M | Buy |
504,781
+437,676
| +652% | +$35.4M | 0.26% | 104 |
|
|
2016
Q3 | $5.97M | Sell |
67,105
-341,766
| -84% | -$32.3M | 0.04% | 378 |
|
|
2016
Q2 | $39.1M | Sell |
408,871
-237,360
| -37% | -$23.7M | 0.33% | 70 |
|
|
2016
Q1 | $67M | Buy |
646,231
+111,037
| +21% | +$10.8M | 0.65% | 26 |
|
|
2015
Q4 | $52.3M | Sell |
535,194
-380,803
| -42% | -$37.3M | 0.49% | 48 |
|
|
2015
Q3 | $88.4M | Buy |
915,997
+88,016
| +11% | +$9.25M | 1.09% | 12 |
|
|
2015
Q2 | $86.8M | Sell |
827,981
-4,822
| -0.6% | -$493K | 1.13% | 8 |
|
|
2015
Q1 | $86M | Buy |
832,803
+745,671
| +856% | +$75.5M | 1.12% | 10 |
|
|
2014
Q4 | $8.39M | Sell |
87,132
-241,803
| -74% | -$21.3M | 0.11% | 220 |
|
|
2014
Q3 | $26.2M | Buy |
328,935
+231,750
| +238% | +$18.3M | 0.38% | 69 |
|
|
2014
Q2 | $7.33M | Buy |
+97,185
| New | +$7.34M | 0.11% | 220 |
|
Other funds holding CVS
VCM
VPM
Marshall Wace's CVS Position: Q1 2026 in Review
Marshall Wace increased its CVS Health (CVS) stake by 5,129% in Q1 2026, buying an estimated $61M and bringing the position to 807,534 shares worth $58M. The position accounts for 0.06% of the portfolio, ranked #314.
Marshall Wace first reported a position in CVS in Q2 2014 and has held it in 44 quarters since. The position peaked at $383M in Q4 2023. 1,866 funds tracked by Wall St. Rank hold CVS as of Q1 2026.
- Marshall Wace held 807,534 shares of CVS Health worth $58M as of Q1 2026.
- Marshall Wace bought 792,090 CVS Health shares in Q1 2026, an estimated $61M.
- CVS Health made up 0.06% of Marshall Wace's portfolio in Q1 2026, its #314 holding.
- Marshall Wace first reported a position in CVS Health in Q2 2014 and has held it in 44 quarters since.
- Marshall Wace's CVS Health position peaked at $383M in Q4 2023.
- 1,866 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.
Based on Marshall Wace's 13F filing for Q1 2026, filed 15 May 2026.